BeStock  
Stocks › CTKB

Cytek Biosciences CTKB

US equityMarket cap rank #3517
$5.34 −$0.04 (-0.74%)
Pre-market · Oct 8, 8:20 am ET · After hours $5.34 0.00%
Open$5.21
Prev close$5.38
Day range$5.11 – $5.34
Volume1.78M
Market cap$694.11M
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±10.4%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+36.0%
Worst reaction-24.0%

Stock move on the day after each report

+12.4%2023/Q3-11.9%2023/Q4-1.1%2024/Q1-9.4%2024/Q2+36.0%2024/Q3-6.7%2024/Q4-22.8%2025/Q1+5.7%2025/Q2+13.2%2025/Q3+1.8%2025/Q4-6.3%2026/Q1-0.5%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q25 Aug 2026After Market–-0.48%–
2026/Q17 May 2026After Market–-6.30%–
2025/Q426 Feb 2026After Market–+1.82%–
2025/Q35 Nov 2025After Market–+13.22%–
2025/Q26 Aug 2025After Market–+5.66%–
2025/Q18 May 2025After Market–-22.82%–
2024/Q427 Feb 2025After Market–-6.65%–
2024/Q35 Nov 2024After Market±38.2%+36.03%Within range
2024/Q26 Aug 2024After Market±45.9%-9.43%Within range
2024/Q18 May 2024After Market±23.1%-1.12%Within range
2023/Q428 Feb 2024After Market±21.7%-11.90%Within range
2023/Q37 Nov 2023After Market–+12.36%–
2023/Q28 Aug 2023After Market±16.3%+0.78%Within range
2023/Q19 May 2023After Market±15.7%-24.04%Bigger than priced
2022/Q428 Feb 2023After Market–-7.86%–
2022/Q39 Nov 2022After Market±18.6%+5.33%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Product$32.56M 67.6%
  • Service$15.58M 32.4%

Latest reported quarter: Q2, ended Jun 2026

Revenue$48.14M+5.6% YoY
Operating profit-$11.40M-7.3% YoY
Net profit-$12.16M-117.8% YoY
Diluted EPS-$0.09-125.0% YoY
Free cash flow-$877,000.00+43.2% YoY
Operating cash flow$1.37M

Revenue, last 8 quarters

$51.5MSep '24$57.5MDec '24$41.5MMar '25$45.6MJun '25$52.3MSep '25$62.1MDec '25$44.1MMar '26$48.1MJun '26

Net profit, last 8 quarters

$941.0KSep '24$9.6MDec '24$-11.4MMar '25$-5.6MJun '25$-5.5MSep '25$-44.1MDec '25$-18.9MMar '26$-12.2MJun '26

Profitability & balance sheet

Gross margin53.2%
Operating margin-21.6%
Net margin-39.0%
Return on equity-23.0%
Return on assets-17.1%
Return on invested capital-21.9%
Current ratio4.48
Liabilities / assets28.0%
Cash & investments$262.00M
Total debt$23.19M
Net cash (debt)$238.81M

Discussion

No comments yet — be the first to weigh in on CTKB.

Leave a comment

Scroll to Top